bpc-157 safety regulatory status fda warning letters bpc 157 I'm sure your patients hit you up about bpc 157 – FDA advisory committee votes to

Intramuscular (IM) B12 injections using hydroxocobalamin, the preferred licensed form in the UK are recommended when: Oral supplementation has failed to correct a documented deficiency The patient has difficulty adhering to daily oral regimens Serum B12 levels remain persistently low despite adequate oral dosing There is clinical evidence of neurological or haematological complications In line with BNF guidance, the standard IM regimen for confirmed deficiency without neurological involvement is a loading course of 1 mg hydroxocobalamin on alternate days for two weeks , followed by maintenance of 1 mg every three months

I would like to believe they do so out of ignorance of the down side

It is rare in plant-based products, so people with a vegan diet can often suffer from vitamin B12 deficiency and related symptoms

Regulatory Status of Peptide Compounding in 2025